

(ShareCast News) - Pharmaceutical group Vectura has posted a 57% rise in interim earnings before interest, tax, depreciation and amortisation to £4.7m...


(ShareCast News) - Vectura and giant Swiss partner Novartis have received US drug regulator approval for their combination treatment for patients with...